CEN/TC 206
| Registration number (WIID) | Project No. | Title | Status |
|---|---|---|---|
| 9493 | LVS EN ISO 10993-7:2009 | Biological evaluation of medical devices - Part 7: Ethylene oxide sterilization residuals (ISO 10993-7:2008) | Standarts spēkā |
| 33857 | LVS EN ISO 10993-7:2009 /AC:2010 | Biological evaluation of medical devices - Part 7: Ethylene oxide sterilization residuals - Technical Corrigendum 1 (ISO 10993-7:2008/Cor 1:2009) | Standarts spēkā |
| 78994 | EN ISO 10993-17:2023/A1:2025 | Biological evaluation of medical devices - Part 17: Toxicological risk assessment of medical device constituents - Amendment 1 (ISO 10993-17:2023/Amd 1:2025) | Standarts spēkā |
| 78989 | EN ISO 10993-12:2021/A1:2025 | Biological evaluation of medical devices - Part 12: Sample preparation and reference materials - Amendment 1 (ISO 10993 12:2021/Amd 1:2025) | Standarts spēkā |
| 67187 | EN ISO 10993-10:2023 | Biological evaluation of medical devices - Part 10: Tests for skin sensitization (ISO/DIS 10993-10:2020) | Standarts spēkā |
| 65480 | EN ISO 22442-1:2020 | Medical devices utilizing animal tissues and their derivatives - Part 1: Application of risk management (ISO/DIS 22442-1:2018) | Standarts spēkā |
| 38319 | LVS EN ISO 10993-6:2017 | Biological evaluation of medical devices - Part 6: Tests for local effects after implantation (ISO 10993-6:2016) | Standarts spēkā |
| 22089 | LVS EN ISO 10993-5:2009 | Biological evaluation of medical devices - Part 5: Tests for in vitro cytotoxicity (ISO 10993-5:2009) | Standarts spēkā |
| 60722 | LVS EN ISO 10993-9:2021 | Biological evaluation of medical devices - Part 9: Framework for identification and quantification of potential degradation products (ISO 10993-9:2019) | Standarts spēkā |
| 77939 | EN ISO 10993-4:2017/A1:2025 | Biological evaluation of medical devices - Part 4: Selection of tests for interactions with blood - Amendment 1 (ISO 10993-4:2017/Amd 1:2025, Corrected version 2025-04) | Standarts spēkā |
Displaying 31-40 of 198 results.